What is the most likely cause of a clear urethral discharge in a sexually active young adult when Gram stain shows many neutrophils but no organisms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chlamydia trachomatis is the Most Likely Organism

In a sexually active young adult with clear urethral discharge and numerous white blood cells but no organisms on Gram stain, Chlamydia trachomatis is the most likely causative pathogen, accounting for 23-55% of nongonococcal urethritis cases. 1

Diagnostic Reasoning

The clinical scenario describes nongonococcal urethritis (NGU), which is diagnosed when Gram-negative intracellular diplococci (gonorrhea) cannot be identified on urethral smears despite evidence of urethral inflammation. 1

Why Chlamydia is Most Likely:

  • C. trachomatis is the most frequent cause of NGU, responsible for 15-55% of cases depending on the population studied 1
  • Clear or mucopurulent discharge is characteristic of chlamydial infection, in contrast to the typically more purulent discharge of gonorrhea 2
  • Chlamydial urethritis in men often produces less profuse discharge than gonorrhea and symptoms may be mild or absent 2
  • The presence of numerous WBCs (>5 per oil immersion field) confirms urethritis, and the absence of organisms on Gram stain rules out gonorrhea 1

Other Organisms in the Differential

Ureaplasma urealyticum:

  • Implicated in up to one-third of nonchlamydial NGU cases 1
  • However, it is less common than Chlamydia overall and specific diagnostic tests are not routinely indicated 1
  • Ureaplasma frequently colonizes healthy individuals without causing symptoms 3

Mycoplasma genitalium:

  • Also implicated in up to one-third of nonchlamydial NGU cases 1
  • Specific testing is not routinely available or indicated in most clinical settings 1

Trichomonas vaginalis:

  • Sometimes causes NGU but is much less common than Chlamydia in men 1
  • Diagnostic testing is reserved for cases not responsive to standard therapy 1

Critical Management Points

Empiric treatment should cover both gonorrhea and chlamydia when diagnostic tools are unavailable or follow-up is uncertain, because coinfection rates can reach 20-40% in certain populations 2

Treatment Recommendations:

  • Azithromycin 1 g orally as a single dose OR Doxycycline 100 mg orally twice daily for 7 days 1
  • Single-dose regimens improve compliance and allow directly observed therapy 1
  • All sexual partners from the past 60 days must be evaluated and treated 1

Common Pitfalls to Avoid:

  • Do not rely on discharge characteristics alone for diagnosis—substantial overlap exists between gonorrhea and chlamydia presentations 2
  • Do not assume absence of discharge excludes infection—asymptomatic carriage is common in both sexes 2
  • Do not treat for Ureaplasma without documented urethritis symptoms or objective signs of inflammation 3
  • Do not defer testing for both gonorrhea and chlamydia—nucleic acid amplification tests (NAATs) are required for accurate detection and are more sensitive than culture 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Discharge Characteristics and Management of Gonorrhea and Chlamydia (CDC Guidelines)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ureaplasma Infection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.